Updated: January 9, 2026
Anoro Ellipta (Umeclidinium/Vilanterol) Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

- Boxed Warning: LABA and Asthma Risk
- Most Common Side Effects of Anoro Ellipta
- Serious Side Effects — Call Your Doctor or Seek Emergency Care
- 1. Worsening of Narrow-Angle Glaucoma
- 2. Urinary Retention
- 3. Cardiovascular Effects
- 4. Paradoxical Bronchospasm
- 5. Low Potassium (Hypokalemia)
- 6. High Blood Sugar (Hyperglycemia)
- 7. Severe Allergic Reactions
- Who Is at Higher Risk for Side Effects?
- The Bottom Line
Overview
What are the side effects of Anoro Ellipta? Learn what's common, what's serious, and when to call your doctor about umeclidinium/vilanterol side effects.
Is Umeclidinium/Vilanterol in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Umeclidinium/Vilanterol near you.
Anoro Ellipta (umeclidinium/vilanterol) is generally well-tolerated by most COPD patients, but like all prescription medications, it can cause side effects. Understanding which side effects are common and expected — versus which ones require immediate medical attention — helps you use this inhaler safely and confidently.
This guide covers everything from the most frequently reported mild side effects to the serious warnings outlined in the FDA prescribing information.
Boxed Warning: LABA and Asthma Risk
Anoro Ellipta contains vilanterol, a long-acting beta-2 agonist (LABA). LABAs carry an FDA boxed warning: when used as monotherapy for asthma, LABAs increase the risk of asthma-related death. However, Anoro Ellipta is NOT approved or indicated for asthma. It is only for COPD. If you have both COPD and asthma, talk to your doctor about appropriate therapy that includes an inhaled corticosteroid.
Check live stock now.
Most Common Side Effects of Anoro Ellipta
In clinical trials involving 8,138 COPD subjects, the most common side effects reported with Anoro Ellipta (occurring in ≥1% of patients and more frequently than placebo) were:
- Pharyngitis (sore throat)
- Sinusitis (sinus infection)
- Lower respiratory tract infection
- Constipation
- Diarrhea
- Pain in extremity (arm or leg pain)
- Muscle spasms
- Neck pain
- Chest discomfort
- Headache
Most common side effects are mild and often improve as your body adjusts to the medication. If any of these significantly bother you, let your doctor know.
Serious Side Effects — Call Your Doctor or Seek Emergency Care
While less common, Anoro Ellipta can cause serious side effects that require prompt medical evaluation:
1. Worsening of Narrow-Angle Glaucoma
Umeclidinium (the anticholinergic component) can worsen narrow-angle glaucoma, which can lead to blindness if untreated. Symptoms include: eye pain or discomfort, blurred vision, red eyes, or seeing halos around lights. Contact your doctor immediately if you develop any of these symptoms.
2. Urinary Retention
Anoro Ellipta can make it harder to empty your bladder, especially in men with an enlarged prostate. Stop using Anoro Ellipta and call your doctor right away if you have: difficulty urinating, a weak urine stream, pain when urinating, or frequent urination.
3. Cardiovascular Effects
Vilanterol (the LABA component) may cause: increased heart rate (tachycardia), elevated blood pressure, or irregular heartbeat (arrhythmia). Use with caution if you have coronary artery disease, cardiac arrhythmias, or hypertension. Get medical attention immediately if your systolic blood pressure is 180 mmHg or higher.
Found
Rate
on average
4. Paradoxical Bronchospasm
Rarely, Anoro Ellipta can cause breathing to worsen immediately after using the inhaler — the opposite of the intended effect. If your breathing gets significantly worse right after using Anoro Ellipta, stop using it and use your rescue inhaler. Call your doctor or go to the emergency room.
5. Low Potassium (Hypokalemia)
LABAs like vilanterol can lower blood potassium levels (hypokalemia), which can cause: muscle weakness, cramping, irregular heartbeat, or fatigue. This risk is higher if you also take diuretics. Your doctor may periodically check your potassium levels.
6. High Blood Sugar (Hyperglycemia)
Anoro Ellipta may increase blood sugar levels, which is particularly important for patients with diabetes. Monitor your blood sugar as directed if you have diabetes, and tell your doctor if you notice increased thirst, frequent urination, or unexplained weight loss.
7. Severe Allergic Reactions
In rare cases, Anoro Ellipta can cause anaphylaxis. The inhaler contains lactose monohydrate with milk proteins — patients with severe milk protein allergy should not use Anoro Ellipta. Seek emergency medical help if you develop: hives, swelling of the face or throat, difficulty breathing after using the inhaler.
Who Is at Higher Risk for Side Effects?
Certain patients require extra caution or monitoring when using Anoro Ellipta:
- Patients with narrow-angle glaucoma (glaucoma worsening risk)
- Men with benign prostatic hyperplasia or bladder obstruction (urinary retention risk)
- Patients with cardiovascular disease, arrhythmias, or hypertension (cardiac monitoring advised)
- Patients with diabetes (blood sugar monitoring)
- Patients with severe milk protein allergy (contraindicated)
The Bottom Line
For most COPD patients, Anoro Ellipta's most common side effects are mild and manageable. Serious side effects are less common but real — knowing what to watch for helps you respond quickly and stay safe. Be sure to discuss your medical history fully with your doctor before starting, and review Anoro Ellipta drug interactions as well. If you're having trouble finding Anoro Ellipta at your pharmacy, medfinder can help you locate it quickly.
Frequently Asked Questions
The most common side effects of Anoro Ellipta (umeclidinium/vilanterol) reported in clinical trials include sore throat (pharyngitis), sinusitis, lower respiratory tract infection, constipation, diarrhea, muscle spasms, and headache. These effects are generally mild and often improve over time as your body adjusts.
Anoro Ellipta contains vilanterol, a LABA that can increase heart rate, raise blood pressure, and in rare cases cause arrhythmias. Patients with existing cardiovascular conditions should discuss this risk with their doctor. In clinical trials, serious cardiac events were rare but monitored closely. Use Anoro Ellipta with caution if you have coronary artery disease, arrhythmias, or uncontrolled hypertension.
Yes. The anticholinergic component umeclidinium can cause urinary retention — difficulty emptying the bladder — especially in men with an enlarged prostate (BPH). If you experience difficulty urinating, weak urine stream, or painful urination, stop using Anoro Ellipta and contact your doctor immediately.
Do not stop Anoro Ellipta without talking to your doctor first, even if you experience side effects. Stopping a COPD maintenance inhaler abruptly can worsen your breathing. Call your doctor to discuss your symptoms. For potentially serious side effects like chest pain, severe breathing difficulty, or eye pain, seek emergency care immediately.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Umeclidinium/Vilanterol also looked for:
More about Umeclidinium/Vilanterol
39,453 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





